EU-MEDICAL_DEVICES_REGULATION-ANX_I_SEC_10

Medical Devices Regulation - Hazardous Substances

EU. Hazardous Substances for Purposes of Medical Devices Regulation 2017/745/EU, 5 May 2017, as amended by Regulation 2020/561/EU, 24 April 2020

This list contains hazardous substances for purposes of the Medical Devices Regulation (MDR), based on the legislation's Annex I general safety and performance requirements, including for chemical, physical and biological properties. Specifically, the non-exhaustive database is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list).

Last updated 26 srpnja 2024. Database contains 4917 unique substances/entries.

Filter the list

Prikaz 2.151 - 2.200 od 4.917 rezultata.

Substance Name	EC No.	CAS No.	EU CLP (1272/2008)	EU REACH: List of SVHC
1-(1-naphthylmethyl)quinolinium chloride CIB R634	406-220-7	65322-65-8	Carc. 2; Muta. 2; Acute Tox. 4; Skin Irrit. 2; Eye Dam. 1		Details
thiophanate-methyl (ISO); dimethyl (1,2-phenylenedicarbamothioyl)biscarbamate; dimethyl 4,4'-(o-phenylene) bis(3-thioallophanate)	245-740-7	23564-05-8	Carc. 2; Muta. 2; Acute Tox. 4; Skin Sens. 1		Details
C.I. Solvent Yellow 14; 1-phenylazo-2-naphthol	212-668-2	842-07-9	Carc. 2; Muta. 2; Skin Sens. 1		Details
methylmercuric chloride	204-064-2	115-09-3	Carc. 2; Repr. 1A; Lact.; Acute Tox. 2; STOT RE 1		Details
lead acetate, basic	215-630-3	1335-32-6	Carc. 2; Repr. 1A; STOT RE 2		Details
epoxiconazole (ISO); (2RS,3SR)-3-(2-chlorophenyl)-2-(4-fluorophenyl)-[(1H-1,2,4-triazol-1-yl)methyl]oxirane	406-850-2	133855-98-8	Carc. 2; Repr. 1B		Details
nitrobenzene	202-716-0	98-95-3	Carc. 2; Repr. 1B; Acute Tox. 3; STOT RE 1	R Toxic for reproduction (article 57c)	Details
carbetamide (ISO); (R)-1-(ethylcarbamoyl) ethyl carbanilate; (2R)-1-(ethylamino)-1-oxopropan-2-yl phenylcarbamate	240-286-6	16118-49-3	Carc. 2; Repr. 1B; Acute Tox. 4		Details
flusilazole (ISO); bis(4-fluorophenyl)(methyl)(1H-1,2,4-triazol-1-ylmethyl)silane	617-717-5	85509-19-9	Carc. 2; Repr. 1B; Acute Tox. 4		Details
reaction mass of: 4-[[bis-(4-fluorophenyl)methylsilyl]methyl]-4H-1,2,4-triazole; 1-[[bis-(4-fluorophenyl)methylsilyl]methyl]-1H-1,2,4-triazole R 7623 TECHNICAL	403-250-2	-	Carc. 2; Repr. 1B; Acute Tox. 4		Details
tris(2-chloroethyl)phosphate	204-118-5	115-96-8	Carc. 2; Repr. 1B; Acute Tox. 4	R Toxic for reproduction (article 57c)	Details
thiacloprid (ISO); (Z)-3-(6-chloro-3-pyridylmethyl)-1,3-thiazolidin-2-ylidenecyanamide; {(2Z)-3-[(6-chloropyridin-3-yl)methyl]-1,3-thiazolidin-2-ylidene}cyanamide	601-147-9	111988-49-9	Carc. 2; Repr. 1B; Acute Tox. 4; Acute Tox. 3; STOT SE 3		Details
ammonium nonadecafluorodecanoate	221-470-5	3108-42-7	Carc. 2; Repr. 1B; Lact.	R Toxic for reproduction (article 57c) PBT Persistent, Bioaccumulative and Toxic (article 57d)	Details
nonadecafluorodecanoic acid	206-400-3	335-76-2	Carc. 2; Repr. 1B; Lact.	R Toxic for reproduction (article 57c) PBT Persistent, Bioaccumulative and Toxic (article 57d)	Details
sodium nonadecafluorodecanoate	-	3830-45-3	Carc. 2; Repr. 1B; Lact.	R Toxic for reproduction (article 57c) PBT Persistent, Bioaccumulative and Toxic (article 57d)	Details
Ammonium salts of perfluorononan-1-oic-acid	-	4149-60-4	Carc. 2; Repr. 1B; Lact.; Acute Tox. 4; STOT RE 1; Eye Dam. 1	R Toxic for reproduction (article 57c) PBT Persistent, Bioaccumulative and Toxic (article 57d)	Details
ammoniumpentadeca-fluorooctanoate	223-320-4	3825-26-1	Carc. 2; Repr. 1B; Lact.; Acute Tox. 4; STOT RE 1; Eye Dam. 1	R Toxic for reproduction (article 57c) PBT Persistent, Bioaccumulative and Toxic (article 57d)	Details
perfluorononan-1-oic acid	206-801-3	375-95-1	Carc. 2; Repr. 1B; Lact.; Acute Tox. 4; STOT RE 1; Eye Dam. 1	R Toxic for reproduction (article 57c) PBT Persistent, Bioaccumulative and Toxic (article 57d)	Details
perfluorononan-1-oic acid sodium salts	-	21049-39-8	Carc. 2; Repr. 1B; Lact.; Acute Tox. 4; STOT RE 1; Eye Dam. 1	R Toxic for reproduction (article 57c) PBT Persistent, Bioaccumulative and Toxic (article 57d)	Details
perfluorooctanoic acid	206-397-9	335-67-1	Carc. 2; Repr. 1B; Lact.; Acute Tox. 4; STOT RE 1; Eye Dam. 1	R Toxic for reproduction (article 57c) PBT Persistent, Bioaccumulative and Toxic (article 57d)	Details
ammonium perfluorooctanesulfonate; ammonium heptadecafluorooctanesulfonate	249-415-0	29081-56-9	Carc. 2; Repr. 1B; STOT RE 1; Acute Tox. 4; Lact.		Details
diethanolamine perfluorooctane sulfonate	274-460-8	70225-14-8	Carc. 2; Repr. 1B; STOT RE 1; Acute Tox. 4; Lact.		Details
lithium perfluorooctane sulfonate; lithium heptadecafluorooctanesulfonate	249-644-6	29457-72-5	Carc. 2; Repr. 1B; STOT RE 1; Acute Tox. 4; Lact.		Details
perfluorooctane sulfonic acid; heptadecafluorooctane-1-sulfonic acid	217-179-8	1763-23-1	Carc. 2; Repr. 1B; STOT RE 1; Acute Tox. 4; Lact.		Details
potassium perfluorooctanesulfonate; potassium heptadecafluorooctane-1-sulfonate	220-527-1	2795-39-3	Carc. 2; Repr. 1B; STOT RE 1; Acute Tox. 4; Lact.		Details
mancozeb (ISO); manganese ethylenebis(dithiocarbamate) (polymeric) complex with zinc salt	616-995-5	8018-01-7	Carc. 2; Repr. 1B; STOT RE 2; Skin Sens. 1		Details
(E)-3-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol CP-166,221	428-010-4	82413-20-5	Carc. 2; Repr. 1B; Skin Sens. 1		Details
vinclozolin (ISO); N-3,5-dichlorophenyl-5-methyl-5-vinyl-1,3-oxazolidine-2,4-dione	256-599-6	50471-44-8	Carc. 2; Repr. 1B; Skin Sens. 1		Details
Reaction mass of 3-(difluoromethyl)-1-methyl-N-[(1RS,4SR,9RS)-1,2,3,4-tetrahydro-9-isopropyl-1,4-methanonaphthalen-5-yl]pyrazole-4-carboxamide and 3-(difluoromethyl)-1-methyl-N-[(1RS,4SR,9SR)-1,2,3,4-tetrahydro-9-isopropyl-1,4-methanonaphthalen-5-yl]pyrazole-4-carboxamide [≥ 78 % syn isomers ≤ 15 % anti isomers relative content]; isopyrazam	632-619-2	881685-58-1	Carc. 2; Repr. 1B; Skin Sens. 1B		Details
chlorotoluron (ISO); 3-(3-chloro-p-tolyl)-1,1-dimethylurea	239-592-2	15545-48-9	Carc. 2; Repr. 2		Details
N-methoxy-N-[1-methyl-2-(2,4,6-trichlorophenyl)-ethyl]-3-(difluoromethyl)- 1-methylpyrazole-4-carboxamide; pydiflumetofen	817-852-1	1228284-64-7	Carc. 2; Repr. 2		Details
pymetrozine (ISO); (E)-4,5-dihydro-6-methyl-4-(3-pyridylmethyleneamino)-1,2,4-triazin-3(2H)-one	602-927-1	123312-89-0	Carc. 2; Repr. 2		Details
tepraloxydim (ISO); (RS)-(EZ)-2-{1-[(2E)-3-chloroallyloxyimino]propyl}-3-hydroxy-5-perhydropyran-4-ylcyclohex-2-en-1-one	604-715-4	149979-41-9	Carc. 2; Repr. 2		Details
fentin acetate (ISO); triphenyltin acetate	212-984-0	900-95-8	Carc. 2; Repr. 2; Acute Tox. 2; Acute Tox. 3; STOT RE 1; STOT SE 3; Skin Irrit. 2; Eye Dam. 1		Details
fentin hydroxide (ISO); triphenyltin hydroxide	200-990-6	76-87-9	Carc. 2; Repr. 2; Acute Tox. 2; Acute Tox. 3; STOT RE 1; STOT SE 3; Skin Irrit. 2; Eye Dam. 1		Details
chloroform; trichloromethane	200-663-8	67-66-3	Carc. 2; Repr. 2; Acute Tox. 3; Acute Tox. 4; STOT RE 1; Eye Irrit. 2; Skin Irrit. 2		Details
cyanamide; carbanonitril	206-992-3	420-04-2	Carc. 2; Repr. 2; Acute Tox. 3; STOT RE 2; Skin Corr. 1; Skin Sens. 1; Eye Dam. 1		Details
dimoxystrobin (ISO); (2E)-2-{2-[(2,5-dimethylphenoxy)methyl]phenyl}-2-(methoxyimino)-N-methylacetamide; (E)-2-(methoxyimino)-N-methyl-2-[α-(2,5-xylyloxy)-o-tolyl]acetamide	604-712-8	149961-52-4	Carc. 2; Repr. 2; Acute Tox. 4		Details
thiourea; thiocarbamide	200-543-5	62-56-6	Carc. 2; Repr. 2; Acute Tox. 4		Details
quizalofop-P-tefuryl (ISO); (±) tetrahydrofurfuryl (R)-2-[4-(6-chloroquinoxalin-2-yloxy)phenyloxy]propionate PANTERA; QUIZALOFOP-P-TEFURYL	414-200-4	119738-06-6	Carc. 2; Repr. 2; Acute Tox. 4; STOT RE 2		Details
quinoclamine (ISO); 2-amino-3-chloro-1,4-naphthoquinonequinoclamine (ISO); 2-amino-3-chloro-1,4-naphthoquinone	220-529-2	2797-51-5	Carc. 2; Repr. 2; Acute Tox. 4; STOT RE 2; Eye Irrit. 2; Skin Sens. 1A		Details
molinate (ISO);S-ethyl 1-perhydroazepinecarbothioate; S-ethyl perhydroazepine-1-carbothioate	218-661-0	2212-67-1	Carc. 2; Repr. 2; Acute Tox. 4; STOT RE 2; Skin Sens. 1		Details
acetochlor (ISO); 2-chloro-N-(ethoxymethyl)-N-(2-ethyl-6-methylphenyl)acetamide	251-899-3	34256-82-1	Carc. 2; Repr. 2; Acute Tox. 4; STOT SE 3; STOT RE 2; Skin Irrit. 2; Skin Sens. 1		Details
clorofene; chlorophene; 2-benzyl-4-chlorophenol	204-385-8	120-32-1	Carc. 2; Repr. 2; Acute Tox. 4; Skin Irrit. 2; Skin Sens. 1; Eye Dam. 1; STOT RE 2		Details
dodecachloropentacyclo[5.2.1.02,6.03,9.05,8]decane; mirex	219-196-6	2385-85-5	Carc. 2; Repr. 2; Lact.; Acute Tox. 4		Details
(RS)-1-{1-ethyl-4-[4-mesyl-3-(2-methoxyethoxy)-o-toluoyl]pyrazol-5-yloxy} ethyl methyl carbonate; tolpyralate	701-225-3	1101132-67-5	Carc. 2; Repr. 2; STOT RE 2		Details
benfluralin (ISO); N-butyl-N-ethyl-α,α,α-trifluoro-2,6-dinitro-p-toluidine	217-465-2	1861-40-1	Carc. 2; Repr. 2; Skin Irrit. 2; Eye Irrit. 2; Skin Sens. 1		Details
profoxydim (ISO); 2-{(EZ)-1-[(2RS)-2-(4-chlorophenoxy)propoxyimino]butyl}-3-hydroxy-5-(thian-3-yl)cyclohex-2-en-1-one	604-105-8	139001-49-3	Carc. 2; Repr. 2; Skin Sens. 1		Details
3,3'-dimethylbiphenyl-4,4'-diyl diisocyanate	202-112-7	91-97-4	Carc. 2; Resp. Sens. 1; Skin Sens. 1A		Details
pentachloroethane	200-925-1	76-01-7	Carc. 2; STOT RE 1		Details

Prikaz 2.151 - 2.200 od 4.917 rezultata.

Export search results to:

EU-MEDICAL_DEVICES_REGULATION-ANX_I_SEC_10

EU-MEDICAL_DEVICES_REGULATION-ANX_I_SEC_10

Medical Devices Regulation - Hazardous Substances

EU. Hazardous Substances for Purposes of Medical Devices Regulation 2017/745/EU, 5 May 2017, as amended by Regulation 2020/561/EU, 24 April 2020

RELEVANT LEGISLATION

Contact EUCLEF Helpdesk

Contact Helpdesk

Last updated 26 srpnja 2024. Database contains 4917 unique substances/entries.

Footer Nav Items